Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05542329

Efficiency of a Telemedicine-based Follow-up on for the Medical Management of Patients Leaving the Intensive Care Unit

Patients surviving to a stay in intensive care unit (ICU) are likely to require specific care and follow-up after their ICU stay, in order to manage the serious illness at the origin of the ICU stay and any sequelae, but also to adapt the treatments and prevent new complications. At present, there is no specific care chain after ICU.

In order to meet this need, we propose the implementation of a care chain integrating telemedicine at home. We compare the current system (lack of specific follow-up) to follow-up by telemedicine at home.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Care After Going to Intensive Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Service de Réanimation Médicale - CH Dijon, Dijon, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient ≥ 18 years old
  • Patient admitted to ICU
  • Stay in intensive care > 48h
  • Patient having benefited from at least one organ support during the ICU stay: invasive or non-invasive ventilation (including nasal high-flow oxygen therapy), inotropic or vasopressor support, renal replacement therapy)
  • Understanding of the French language
  • Patient or entourage able to carry out the measures proposed by telemedicine
  • Subject affiliated to a social health insurance scheme
  • Subject having signed a consent form

Exclusion criteria

  • Subject under guardianship or curatorship
  • Pregnancy / lactation
  • Voluntary drug poisoning

Treatment and study plan

Monitoring by Tele-Medecine

Device

Monitoring by Tele-Medecine

Primary outcomes

  1. Evaluate the medico-economic of telemedicine monitoring

    Time frame: 12 month

    The main judgment criterion will be the incremental cost-utility ratio of the innovation represented by monitoring by a telemedicine device linked to a nurse coordination unit, compared to the usual monitoring without telemedicine.

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: TéléRéa

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Sep 15, 2022
Registry last updated
Jul 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.